200 related articles for article (PubMed ID: 34332209)
1. Combination therapy of curcumin and fecal microbiota transplant: Potential treatment of polycystic ovarian syndrome.
Corrie L; Gulati M; Vishwas S; Kapoor B; Singh SK; Awasthi A; Khursheed R
Med Hypotheses; 2021 Sep; 154():110644. PubMed ID: 34332209
[TBL] [Abstract][Full Text] [Related]
2. Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics.
Singh S; Pal N; Shubham S; Sarma DK; Verma V; Marotta F; Kumar M
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835989
[TBL] [Abstract][Full Text] [Related]
3. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
Yurtdaş G; Akdevelioğlu Y
J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
[TBL] [Abstract][Full Text] [Related]
4. Roles of the gut virome and mycobiome in faecal microbiota transplantation.
Lam S; Bai X; Shkoporov AN; Park H; Wu X; Lan P; Zuo T
Lancet Gastroenterol Hepatol; 2022 May; 7(5):472-484. PubMed ID: 35276080
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiome and Polycystic Ovary Syndrome: Interplay of Associated Microbial-Metabolite Pathways and Therapeutic Strategies.
Babu A; Devi Rajeswari V; Ganesh V; Das S; Dhanasekaran S; Usha Rani G; Ramanathan G
Reprod Sci; 2024 Jun; 31(6):1508-1520. PubMed ID: 38228976
[TBL] [Abstract][Full Text] [Related]
6. Association between Polycystic Ovary Syndrome and Gut Microbiota.
Guo Y; Qi Y; Yang X; Zhao L; Wen S; Liu Y; Tang L
PLoS One; 2016; 11(4):e0153196. PubMed ID: 27093642
[TBL] [Abstract][Full Text] [Related]
7. Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases.
Quaranta G; Sanguinetti M; Masucci L
Front Immunol; 2019; 10():2653. PubMed ID: 31827467
[TBL] [Abstract][Full Text] [Related]
8. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
[TBL] [Abstract][Full Text] [Related]
9. Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome.
Han Q; Wang J; Li W; Chen ZJ; Du Y
Microbiome; 2021 May; 9(1):101. PubMed ID: 33957990
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of Gut Microbiota Alteration in the Patients and Animal Models with Polycystic Ovary Syndrome.
Zhou J; Qiu X; Chen X; Ma S; Chen Z; Wang R; Tian Y; Jiang Y; Fan L; Wang J
J Microbiol; 2023 Sep; 61(9):821-836. PubMed ID: 37824034
[TBL] [Abstract][Full Text] [Related]
11. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota and Chronic Constipation: A Review and Update.
Ohkusa T; Koido S; Nishikawa Y; Sato N
Front Med (Lausanne); 2019; 6():19. PubMed ID: 30809523
[No Abstract] [Full Text] [Related]
13. Dysbiosis of Gut Microbiota (DOGMA)--a novel theory for the development of Polycystic Ovarian Syndrome.
Tremellen K; Pearce K
Med Hypotheses; 2012 Jul; 79(1):104-12. PubMed ID: 22543078
[TBL] [Abstract][Full Text] [Related]
14. Fecal microbiota transplantation alleviates myocardial damage in myocarditis by restoring the microbiota composition.
Hu XF; Zhang WY; Wen Q; Chen WJ; Wang ZM; Chen J; Zhu F; Liu K; Cheng LX; Yang J; Shu YW
Pharmacol Res; 2019 Jan; 139():412-421. PubMed ID: 30508676
[TBL] [Abstract][Full Text] [Related]
15. Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota.
He Y; Wang Q; Li X; Wang G; Zhao J; Zhang H; Chen W
Food Funct; 2020 Jun; 11(6):5192-5204. PubMed ID: 32441726
[TBL] [Abstract][Full Text] [Related]
16. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
[TBL] [Abstract][Full Text] [Related]
17. Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies.
Corrie L; Awasthi A; Kaur J; Vishwas S; Gulati M; Kaur IP; Gupta G; Kommineni N; Dua K; Singh SK
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259345
[TBL] [Abstract][Full Text] [Related]
18. Insights into New Therapeutic Approaches for the Treatment and Management of Polycystic Ovary Syndrome: An Updated Review.
Bashir R; Wani IA; Ganie MA
Curr Pharm Des; 2022; 28(18):1493-1500. PubMed ID: 35593345
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Evaluation of Gut Bacteriomes and Viromes after Fecal Microbiota Transplantation for Eradication of Carbapenem-Resistant
Liu Q; Zuo T; Lu W; Yeoh YK; Su Q; Xu Z; Tang W; Yang K; Zhang F; Lau LHS; Lui RNS; Chin ML; Wong R; Cheung CP; Zhu W; Chan PKS; Chan FKL; Lui GC; Ng SC
mSystems; 2022 Jun; 7(3):e0151021. PubMed ID: 35642928
[TBL] [Abstract][Full Text] [Related]
20. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation.
Elangovan A; Allegretti JR; Fischer M
Expert Opin Biol Ther; 2019 Dec; 19(12):1343-1355. PubMed ID: 31570017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
